Search Results - "Krychtiuk, K. A."

Refine Results
  1. 1

    Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans by Thaler, B., Hohensinner, P. J., Krychtiuk, K. A., Matzneller, P., Koller, L., Brekalo, M., Maurer, G., Huber, K., Zeitlinger, M., Jilma, B., Wojta, J., Speidl, W. S.

    Published in Scientific reports (22-07-2016)
    “…Human monocytes are a heterogeneous cell population, which can be divided into a classical (CD14++CD16−), a non-classical (CD14+CD16+) and an intermediate…”
    Get full text
    Journal Article
  2. 2

    Inflammation and coagulation in atherosclerosis by Krychtiuk, K A, Kastl, S P, Speidl, W S, Wojta, J

    Published in Hämostaseologie (2013)
    “…Cardiovascular diseases remain to be the leading cause of death in Western societies. Despite major findings in vascular biology that lead to a better…”
    Get more information
    Journal Article
  3. 3

    Interleukin‐33 induces urokinase in human endothelial cells―possible impact on angiogenesis by Stojkovic, S., Kaun, C., Heinz, M., Krychtiuk, K. A., Rauscher, S., Lemberger, C. E., Martin, R., Gröger, M., Petzelbauer, P., Huk, I., Huber, K., Wojta, J., Demyanets, S.

    Published in Journal of thrombosis and haemostasis (01-06-2014)
    “…Summary Background Urokinase‐type plasminogen activator (u‐PA) plays a pivotal role in extracellular proteolysis and is thought to be critically involved in…”
    Get full text
    Journal Article
  4. 4

    Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells by Wu, J., Hafner, C., Schramel, J. P., Kaun, C., Krychtiuk, K. A., Wojta, J., Boehme, S., Ullrich, R., Tretter, E. V., Markstaller, K., Klein, K. U.

    Published in Acta anaesthesiologica Scandinavica (01-04-2016)
    “…Background Perioperative high‐dose oxygen (O2) exposure can cause hyperoxia. While the effect of constant hyperoxia on the vascular endothelium has been…”
    Get full text
    Journal Article
  5. 5

    Can a flowchart improve the quality of bystander cardiopulmonary resuscitation? by Rössler, B, Ziegler, M, Hüpfl, M, Fleischhackl, R, Krychtiuk, K.A, Schebesta, K

    Published in Resuscitation (01-07-2013)
    “…Abstract Background Since the introduction of basic life support in the 1950s, on-going efforts have been made to improve the quality of bystander…”
    Get full text
    Journal Article
  6. 6

    Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes by Bernhard, J, Engelberger, K, Galli, L, Haider, P, Ungersbaeck, K, Hengstenberg, C, Speidl, W S, Krychtiuk, K A

    Published in European heart journal (09-11-2023)
    “…Abstract Background Toll-like receptor 4 (TLR4) is a key regulator of both innate and adaptive immune responses and its functions affects the initiation and…”
    Get full text
    Journal Article
  7. 7

    Association of inflammatory activation with acute stent thrombosis by Krychtiuk, K A, Braeu, K, Schauer, S, Sator, A, Galli, L, Gangl, C, Roth, C, Hengstenberg, C, Lang, I M, Berger, R, Speidl, W S

    Published in European heart journal (09-11-2023)
    “…Abstract Background Acute stent thrombosis (ST) is a rare but deleterious event. Acute infection and inflammation may lead to activation of the coagulation…”
    Get full text
    Journal Article
  8. 8

    Decreased levels of plasmacytoid dendritic cells predict survival in critically ill patients by Steinacher, E, Lenz, M, Krychtiuk, K A, Hengstenberg, C, Huber, K, Wojta, J, Heinz, G, Niessner, A, Speidl, W S, Koller, L

    Published in European heart journal (09-11-2023)
    “…Abstract Background Critically ill patients admitted to intensive care units (ICUs) exhibit high mortality rates and suffer from a broad variety of…”
    Get full text
    Journal Article
  9. 9

    Lipid-lowering therapy and LDL-cholesterol in patients after acute coronary syndromes by Haider, P, Galli, L, Schrutka, L, Distelmaier, K, Wojta, J, Hengstenberg, C, Krychtiuk, K A, Speidl, W S

    Published in European journal of preventive cardiology (24-05-2023)
    “…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Medical University of Vienna. Background Intensive lipid…”
    Get full text
    Journal Article
  10. 10

    P789TLR-4 expression predicts mortality in patients with acute heart failure by Krychtiuk, K A, Lenz, M, Huber, K, Hengstenberg, C, Wojta, J, Heinz, G, Speidl, W S

    Published in European heart journal (01-10-2019)
    “…Abstract Background Inflammation is regarded as an important trigger for disease progression in heart failure (HF) and activation of the inflammatory system…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease by Krychtiuk, KA, Lenz, M, Hohensinner, P, Distelmaier, K, Schrutka, L, Kastl, SP, Huber, K, Hengstenberg, C, Wojta, J, Speidl, WS

    Published in European journal of preventive cardiology (11-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): FWF Background and aims Proprotein…”
    Get full text
    Journal Article
  16. 16

    Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue by Pentz, Richard, Kaun, Christoph, Thaler, Barbara, Stojkovic, Stefan, Lenz, Max, Krychtiuk, Konstantin A., Zuckermann, Andreas, Huber, Kurt, Wojta, Johann, Hohensinner, Philipp J., Demyanets, Svitlana

    Published in Journal of cellular and molecular medicine (01-12-2018)
    “…Interleukin (IL)‐33 is a member of the IL‐1 family and is able to act cardioprotective. The aim of this study was to investigate the regulation of IL‐33 by…”
    Get full text
    Journal Article
  17. 17

    Soluble neprilysin and survival in critically ill patients by Lenz, M, Krychtiuk, KA, Brekalo, M, Hengstenberg, C, Huber, K, Heinz, G, Wojta, J, Speidl, WS

    “…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): -) Association for the Promotion of…”
    Get full text
    Journal Article
  18. 18

    Soluble neprilysin and survival in critically ill patients by Lenz, M, Krychtiuk, KA, Brekalo, M, Draxler, DF, Pavo, N, Hengstenberg, C, Huber, K, Huelsmann, M, Heinz, G, Wojta, J, Speidl, WS

    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Critically ill patients admitted to an intensive care unit (ICU) exhibit a high…”
    Get full text
    Journal Article
  19. 19

    Indications, outcomes and complications after ECMO implantation in the cath lab - a single-center retrospective study by Kralicek, S, Meier, CS, Distelmaier, K, Niessner, A, Heinz, G, Lang, IM, Hengstenberg, C, Krychtiuk, KA, Speidl, WS

    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Despite the increase of extracorporeal membrane oxygenation (ECMO) employment…”
    Get full text
    Journal Article
  20. 20